Distinct patterns of Bcl-2 expression occur in R5- and X4-tropic HIV-1-producing lymphoid tissue cells infected ex vivo

AIDS Research and Human Retroviruses

Volumn 31, Issue 3, 2015, Pages 298-304

  Haas, Michelle K ^a,b   Levy, David N ^c   Folkvord, Joy M ^a   Connick, Elizabeth ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DENVER PUBLIC HEALTH   (United States)

^c NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR5; PROTEIN BCL 2; CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, HUMAN; CXCR5 PROTEIN, HUMAN; VIRUS RECEPTOR;

ARTICLE; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL SURFACE; CELL SURVIVAL; CHILD; EX VIVO STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IN VITRO STUDY; LYMPHOID TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TONSIL CELL; VIRUS REPLICATION; ADOLESCENT; BIOSYNTHESIS; CHEMISTRY; FEMALE; GENE EXPRESSION PROFILING; GROWTH, DEVELOPMENT AND AGING; IMMUNOPHENOTYPING; MALE; PATHOLOGY; PRESCHOOL CHILD; VIROLOGY;

ADOLESCENT; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION PROFILING; HIV-1; HUMANS; IMMUNOPHENOTYPING; LYMPHOID TISSUE; MALE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CXCR4; RECEPTORS, CXCR5; RECEPTORS, HIV;

EID: 84924277467     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2014.0155     Document Type: Article

References (50)

1. Pantaleo G, Graziosi C, Demarest JF, et al.: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-358.
2. Embretson J, Zupancic M, Ribas JL, et al.: Massive covert infection of helper T lymphocytes and macrophages by HICV during the incubation period of AIDS. Nature 1993;362:359-362.
3. Tamalet C, Lafeuillade A, Fantini J, et al.: Quantification of HIV-1 viral load in lymphoid and blood cells: Assessment during four-drug combination therapy. AIDS 1997;11(7):895-901.
4. Yang OO, Ferbas JJ, Hausner MA, et al.: Effects of HIV-1 infection on lymphocyte phenotypes in blood versus lymph nodes. J Acquir Immune Defic Syndr 2005;39(5):507-518.
5. Spiegel H, Herbst H, Niedobitek G, et al.: Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4 + T-helper cells. Am J Pathol 1992;140(1):15-22.
6. Tenner-Racz K and Racz P: Follicular dendritic cells initiate and maintain infection of the germinal centers by human immunodeficiency virus. Curr Top Microbiol Immunol 1995;201:141-159.
7. Hufert FT, Lunzen JV, Janossy G, et al.: Germina centre CD4 + T cells are an important site of HIV replication in vivo. AIDS 1997;11:849-857.
8. Meditz AL, Folkford JM, Lyle NH, et al.: CCR5 expression is reduced in lymph nodes of HIV-1 infected women compared to men but does not mediate sex differences in viral loads. J Infect Dis 2014;209(6):922-930.
9. Folkvord JM, Armon C, and Connick E: Lymphoid follicles are sites of heightened human immunodeficiency virus type 1 (HIV-1) replication and reduced antiretroviral effector mechanisms. AIDS Res Hum Retroviruses 2005;21(5):363-370.
10. Legler DF, Loetscher M, Roos RS, et al.: B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med 1998;187(4):665-660.
11. Breitfeld D, Ohl L, Kremmer E, et al.: Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles and support immunoglobulin production. J Exp Med 2000;192(11):1545-1551.
12. Ansel KM, Ngo VN, Hyman PL, et al.: A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000;406:309-314.
13. Gunn MD, Ngo VN, Ansel KM, et al.: A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 1998;391:779-803.
14. Schaerli P, Willimann K, Lang AB, et al.: CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med 2000;192(11):1553-1562.
15. Palmer BE. Naomi B, and Fontenot AP: Functional and phenotypic characterization of CD57 + CD4 + T cells and their association with HIV-1-induced T cell dysfunction. J Immunol 2005;175:8415-8423.
16. Kim CH, Rott LS, Clark-Lewis I, et al.: Subspecialization of CXCR5 + T cells: B helper activity is focused in a germinal center-localized subset of CXCR5 + T cells. J Exp Med 2001:1373-1382.
17. Bégaud E, Chartier L, Marechal V, et al.: Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology 2006;3:35.
18. Koning FA, Otto SA, Hazenberg MD, et al.: Low-level CD4 + T cell activation is associated with low susceptibility to HIV-1 infection. J Immunol 2005;175(9):6117-6122.
19. Meditz AL, Haas MK, Folkvord JM, et al.: HLA-DR + CD38 + CD4 + T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo. J Virol 2011;85(19):10189-10200.
20. Connick E, Mattila T, Folkvord JM, et al.: CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue. J Immunol 2007;178(11):6975-6983.
21. Akashi K, Kondo M, Freeden-Jeffry V, et al.: Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 1997;89(7):1033-1041.
22. Maraskovsky E, O'Reilly L, Teepe M, et al.: Bcl-2 can rescue T lymphocyte development in interleukin-7 receptordeficient mice but not in mutant rag-1 -/- mice. Cell 1997;89(7):1011-1089.
23. Kim K, Lee C-k, Sayers TJ, et al.: The trophic action of IL-7 on pro-T cells: Inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. J Immunol 1998;160(12):5735-5741.
24. Akbar AN, Borthwick NJ, Wickremasinghe G, et al.: Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur J Immunol 1996;26(2):294-299.
25. Mueller D, Seiffert S, Fang W, and Behrens TW: Differential regulation of bcl-2 and bcl-x by CD3, CD28, and the IL-2 receptor in cloned CD4 + helper T cells. A model for the long-term survival of memory cells. J Immunol 1996;156(5):1764-1771.
26. Ledru E, Lecoeur H, Garcia S, et al.: Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: Correlation with Bcl-2 expression and consequences for AIDS pathogenesis. J Immunol 1998;160(7):3194-3206.
27. Zauli G, Gibellini D, Caputo A, et al.: The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells. Blood 1995;86(10):3823-3834.
28. Sastry K, Marin M, Nehete PM, et al.: Expression of human immunodeficiency virus type I tat results in downregulation of bcl-2 and induction of apoptosis in hematopoietic cells. Oncogene 1996;13(3):487-493.
29. Gougeon M-L: To kill or be killed: How HIV exhausts the immune system. Cell Death Differ 2005;12:845-854.
30. Rasola A, Gramaglia D, Boccaccio C, and Comoglio PM: Apoptosis enhancement by the HIV-1 Nef protein. J Immunol 2001;166(1):81-88.
31. Ndolo T, Dhillon NK, Nguyen H, et al.: Simian immunodeficiency virus Nef protein delays the progression of CD4 + T cells through G1/S phase of the cell cycle. J Virol 2002;76(8):3587-3595.
32. Trushin SA, Carena AA, Bren GD, et al.: SDF-1alpha degrades whereas glycoprotein 120 upregulates Bcl-2 interacting mediator of death extralong isoform: Implications for the development of T cell memory. J Immunol 2012; 189(4):1835-1842.
33. Kutsch O, Benveniste EN, Shaw GM, and Levy DN: Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency. J Virol 2002;76(17):8776-8786.
34. Mahnke YD and Roederer M: Optimizing a multi-colour immunophenotyping assay. Clin Lab Med 2007;27(3):469-v.
35. Guy B, Kieny MP, Riviere Y, et al.: HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 1987;330(6145):266-269.
36. Garcia JV and Miller AD: Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 1991;350:508-511.
37. Marrack P and Kappler J: Control of T cell viability. Annu Rev Immunol 2004;22:765-787.
38. Song J, So T, and Croft M: Activation of NF-kappaB1 by OX40 contributes to antigen-driven T cell expansion and survival. J Immunol 2008;180(11):7240-7248.
39. Miyazaki T, Liu Z-J, Kawahara A, et al.: Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 1995;81(2):2223-2231.
40. Yamada K, Yamakawa M, Imai Y, and Tsukamoto M: Expression of cytokine receptors on follicular dendritic cells. Blood 1997;90(12):4832-4841.
41. Adachi Y, Oyaizu N, Than S, et al.: IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: Correlation with its ability to block culture-induced down-modulation of Bcl-2. J Immunol 1996;157(9):4184-4193.
42. Reed JC, Tsujimoto Y, Alpers JD, et al.: Regulation of Bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science 1987;236(4806):1295-1299.
43. Pepper M, Pagán AJ, Igyártó BZ, et al.: Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity 2011;35(4):583-595.
44. Hashimoto F, Oyaizu N, Kalyanaraman VS, and Pahwa S: Modulation of Bcl-2 protein by CD4 cross-linking: A possible mechanism for lymphocyte apoptosis in human immunodeficiency virus infection and for rescue of apoptosis by interleukin-2. Blood 1997;90(2):745-753.
45. Trushin SA, Algeciras-Schimnich A, Vlahakis SR, et al.: Glycoprotein 120 binding to CXCR4 causes p38-dependent primary T cell death that is facilitated by, but does not require cell-associated CD4. J Immunol 2007;178(8):4846-4853.
46. Lee NJ, Choi DY, Song JK, et al.: Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-{kgreen}B and inhibition of monocyte chemoattractant protein-1 in urethane-induced lung tumor model. Carcinogenesis 2012;33(12):2520-2528.
47. Camargo JF, Quinones MP, Mummidi S, et al.: CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signalling events during T lymphocyte activation. J Immunol 2009;182(1):171-182.
48. Schuitemaker H, Koot M, Kootstra NA, et al.: Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol 1992;66(3):1354-1360.
49. Harouse JM, Buckner C, Gettie A, et al.: CD8 + Tcell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaques. Proc Natl Acad Sci USA 2003;100(19):10977-10982.
50. Doitsh G, Cavrois M, Lassen KG, et al.: Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 2010;143(5):789-801.